Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SALTIRE II: Bisphosphonates and RANKL Inhibition in Aortic Stenosis

Trial Profile

SALTIRE II: Bisphosphonates and RANKL Inhibition in Aortic Stenosis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 26 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Denosumab (Primary) ; Alendronic acid
  • Indications Calcinosis
  • Focus Therapeutic Use
  • Acronyms SALTIRE II
  • Most Recent Events

    • 13 Nov 2023 Results assessing pre-specified secondary analyses of 24-month change in coronary and ascending aorta calcium scores and 12-month change in coronary and aortic 18F-NaF activity ,presented at the American Heart Association Scientific Sessions 2023.
    • 29 Aug 2022 Results (n=136) of post-hoc analysis assessing fibro-calcific aortic valve thickening in patients with aortic valve stenosis and its reproducibility, associations with echo parameters of AS severity and disease progression presented at the ESC Congress 2022 - Annual Congress of the European Society of Cardiology
    • 29 Apr 2021 Results published in the Circulation
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top